Skip to content
Review

miR‑126: A novel regulator in colon cancer (Review)

· 0 citations · 49 references

TL;DR

The expression of miR-126 decreased significantly in colon cancer, particularly in highly metastatic cell lines, indicating that miR-126 may serve as a therapeutic target for anticancer therapy.

View source

Similar papers

Review Open access Sep 2026

miR-218 in breast cancer: friend or foe?

miRNAs are small molecules which influence cellular function by regulating the expression of mRNA. They control various stages of the cell’s existence, including differentiation, proliferation and finally death. In cancer cells, miRNAs can become dysregulated, enabling the cell to escape growth suppression and resist...

Mateusz Gotowiec, Marta Wojtkiewicz-Gotowiec, K. Marcinkowska et al. · 0 citations
Review Aug 2026

The Pivotal Role of miR-770 in Solid Tumors Carcinogenesis

MiR-770 has been introduced as a potential marker in the prognosis of various cancers as well as in the early identification of tumor formation, progression, and metastasis.

Mohsen Davari, Pooran Ghiasizadeh, Mozhgan Mondeali et al. · 0 citations
Review Sep 2026

Integrated roles of miR-125b, miR-375, and miR-451 in breast cancer chemoresistance: mechanistic insights and translational implications

The existing data about the involvement of three important miRNAs, miR-125b, miR-375 and miR-451 in breast cancer chemoresistance, based on the studies gathered from PubMed, Scopus and Web of Science up to December 2025 are summarized.

Danial Ahdi, Samin Rashtchi, Solmaz Hashemi et al. · 0 citations

tumor growth and metastasis by decreasing the expression of PTEN

expression and inhibition of miR-214 indicated that miR-214 acts as an oncogenic miRNA and may contribute to the progression, and metastasis of OS, suggesting that miR-214 may be a potential novel diagnostic and therapeutic target of OS.

Chunjie Liu, Kun-Lun Yu, Guo-li Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.